Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Klingbiel

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
JAMA Oncology|January 16, 2016
Microsatellite Instability and BRAF and KRAS Mutations in Stage III Colon Cancer: Requirements for Accurate Prognosis AssessmentDirk Klingbiel, Sabine Tejpar
European Journal of Cancer (Oxford, England : 1990)|June 12, 2014
Measurement or estimation of glomerular filtration rate in seminoma patients: quite another cup of teaMartin Fehr, Tom Geldart, Dirk Klingbiel, et al.
Journal of Biomedical Informatics|October 21, 2015
High-throughput alternative splicing detection using dually constrained correspondence analysis (DCCA)Florent Baty, Dirk Klingbiel, Francesco Zappa, et al.
The Lancet. Oncology|September 3, 2013
What can we learn from the ZOOM trial?Stefanie Hayoz, Dirk Klingbiel, Peter Brauchli, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2016
Hyperthermia and Radiation Therapy in Locoregional Recurrent Breast Cancers: A Systematic Review and Meta-analysisNiloy R Datta, Emsad Puric, Dirk Klingbiel, et al.
Journal of Hematology & Oncology|March 18, 2017
Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohortDarius Juskevicius, David Jucker, Dirk Klingbiel, et al.
Annals of Hematology|September 30, 2011
Athrombogenic coating of long-term venous catheter for cancer patients: a prospective, randomised, double-blind trialFelicitas Hitz, Dirk Klingbiel, Aurelius Omlin, et al.
Journal of Translational Medicine|April 1, 2017
24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profilingFlorent Baty, Markus Joerger, Martin Früh, et al.
Pharmacoeconomics|March 28, 2014
Using the EuroQol EQ-5D in Swiss cancer patients, which value set should be applied?Klazien Matter-Walstra, Dirk Klingbiel, Thomas Szucs, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 6, 2013
Predictors of satisfaction with treatment decision, decision-making preferences, and main treatment goals in patients with advanced cancerFelicitas Hitz, Karin Ribi, Qiyu Li, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
JAMA Oncology|January 16, 2016
Microsatellite Instability and BRAF and KRAS Mutations in Stage III Colon Cancer: Requirements for Accurate Prognosis AssessmentDirk Klingbiel, Sabine Tejpar
European Journal of Cancer (Oxford, England : 1990)|June 12, 2014
Measurement or estimation of glomerular filtration rate in seminoma patients: quite another cup of teaMartin Fehr, Tom Geldart, Dirk Klingbiel, et al.
Journal of Biomedical Informatics|October 21, 2015
High-throughput alternative splicing detection using dually constrained correspondence analysis (DCCA)Florent Baty, Dirk Klingbiel, Francesco Zappa, et al.
The Lancet. Oncology|September 3, 2013
What can we learn from the ZOOM trial?Stefanie Hayoz, Dirk Klingbiel, Peter Brauchli, et al.
International Journal of Radiation Oncology, Biology, Physics|February 23, 2016
Hyperthermia and Radiation Therapy in Locoregional Recurrent Breast Cancers: A Systematic Review and Meta-analysisNiloy R Datta, Emsad Puric, Dirk Klingbiel, et al.
Journal of Hematology & Oncology|March 18, 2017
Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38/07 prospective clinical trial cohortDarius Juskevicius, David Jucker, Dirk Klingbiel, et al.
Annals of Hematology|September 30, 2011
Athrombogenic coating of long-term venous catheter for cancer patients: a prospective, randomised, double-blind trialFelicitas Hitz, Dirk Klingbiel, Aurelius Omlin, et al.
Journal of Translational Medicine|April 1, 2017
24h-gene variation effect of combined bevacizumab/erlotinib in advanced non-squamous non-small cell lung cancer using exon array blood profilingFlorent Baty, Markus Joerger, Martin Früh, et al.
Pharmacoeconomics|March 28, 2014
Using the EuroQol EQ-5D in Swiss cancer patients, which value set should be applied?Klazien Matter-Walstra, Dirk Klingbiel, Thomas Szucs, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 6, 2013
Predictors of satisfaction with treatment decision, decision-making preferences, and main treatment goals in patients with advanced cancerFelicitas Hitz, Karin Ribi, Qiyu Li, et al.
Pageof 6